Back to Search Start Over

Drugs utilization profile in England and Wales in the past 15 years: a secular trend analysis.

Authors :
Naser AY
Alwafi H
Al-Daghastani T
Hemmo SI
Alrawashdeh HM
Jalal Z
Paudyal V
Alyamani N
Almaghrabi M
Shamieh A
Source :
BMC primary care [BMC Prim Care] 2022 Sep 16; Vol. 23 (1), pp. 239. Date of Electronic Publication: 2022 Sep 16.
Publication Year :
2022

Abstract

Background: Medication use assessment has a critical role in promoting the effective and rational use of pharmaceutical medications. There are no studies that have explored the utilization of all medications in England and Wales in the past 15 years without restrictions in the age group being studied or class of medications.<br />Aim: To explore the medication utilization pattern of dispensed medications in England and Wales in the past 15 years.<br />Method: A secular trend analysis study using publically available dispensing data on the population level in England and Wales for the duration between 2004 and 2019. Medication dispensing data was extracted from the Prescription Cost Analysis database.<br />Results: Medication prescriptions rate increased by 42.6% [from 1,345,095.75 (95% CI 1,345,004.25 - 1,345,187.26) in 2004 to 1,918,138.48 (95% CI 1,918,038.38 - 1,918,238.57) in 2019 per 100,000 persons, trend test, p < 0.001]. During the study period, the most common medication prescriptions were for the cardiovascular system, central nervous system, and endocrine system, which accounted for 30.2%, 18.8%, and 9.4%, respectively. The rate of medication prescriptions for skin, immunological products and vaccines, infections, and musculoskeletal and joint diseases decreased by 18.4%, 15.8%, 9.8%, and 5.7%, respectively.<br />Conclusion: The last two decades have witnessed a remarkable rise in the quantity of medications dispensed in community settings. Utilization of chronic disease medications has increased in the past 15 years, specifically, dispensed medications for the cardiovascular system, central nervous system, and endocrine system. It is necessary to conduct additional cohort studies to investigate the clinical outcomes and prescribing safety of these medications.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2731-4553
Volume :
23
Issue :
1
Database :
MEDLINE
Journal :
BMC primary care
Publication Type :
Academic Journal
Accession number :
36114471
Full Text :
https://doi.org/10.1186/s12875-022-01853-1